Last update: July 12, 2017
Minimal risk for breastfeeding and infant.
Bismuth salts are used alone or together with other components in preparations against gastritis and diarrhea.
Bismuth salicylate contains about 60% bismuth and 40% salicylate.
At latest update no published data on excretion into breast milk were found.
Bismuth is not absorbed into the systemic circulation of the mother.
There may be a risk of absorption of salicylate in the case of bismuth salicylate, although in small quantity (<1% of the maternal dose), but no cases of Reye's syndrome have been reported after taking bismuth salicylate or other non-acetylated salicylate compounds.
Due to the otherwise minimum risk of Reye's syndrome and the indiscriminate use of bismuth subsalicylate for treatment of gastroenteritis cannot be justifiable since most of gastroenteritis do not require medication instead a simply adequate hydration, a safer alternative should be desirable while breastfeeding, like the other salts of bismuth (citrate, etc).
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Confederación Nacional de Pediatría (CONAPEME) from Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM